carbachol has been researched along with Amyotonia Congenita in 2 studies
Carbachol: A slowly hydrolyzed CHOLINERGIC AGONIST that acts at both MUSCARINIC RECEPTORS and NICOTINIC RECEPTORS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Patejdl, R | 1 |
| Klawitter, F | 1 |
| Walter, U | 1 |
| Zanaty, K | 1 |
| Schwandner, F | 1 |
| Sellmann, T | 1 |
| Porath, K | 1 |
| Ehler, J | 1 |
| Venkova, K | 1 |
| Dunn, ST | 1 |
| Adesina, AM | 1 |
| Greenwood-Van Meerveld, B | 1 |
2 other studies available for carbachol and Amyotonia Congenita
| Article | Year |
|---|---|
A novel ex vivo model for critical illness neuromyopathy using freshly resected human colon smooth muscle.
Topics: Aged; Biological Assay; Carbachol; Colon; Critical Illness; Electric Stimulation; Electrophysiology; | 2021 |
Neuromuscular dysfunction in the jejunum and colon of human leukocyte antigen B27 transgenic rats.
Topics: Adrenergic Agents; Animals; Animals, Genetically Modified; Atropine; Carbachol; Colitis; Electric St | 2000 |